-
Je něco špatně v tomto záznamu ?
Cardiac Conduction System as an OAR in Radiation Therapy: Doses to SA/AV Nodes and Their Reduction
M. Domanský, M. Andrlík, S. Kurucz, J. Vilimovský, SA. Salih, D. Šimánková, J. Kubeš
Status neindexováno Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2015
PubMed Central
od 2016
Europe PubMed Central
od 2016
Elsevier Open Access Journals
od 2014-05-01
- Publikační typ
- časopisecké články MeSH
PURPOSE: Despite advancements in radiation techniques, concerns persist regarding the adverse effects of radiation therapy, particularly cardiotoxicity or radiation-induced heart disease. Recently, arrhythmogenic toxicity has come to the forefront-the impact of radiation therapy on the cardiac conduction system. Our objective was to conduct a dosimetric study and subsequently investigate the feasibility of optimizing the sinoatrial (SA) and atrioventricular (AV) nodes as organs at risk (OARs) in proton radiation therapy for non-small cell lung cancer with N3 disease. PATIENTS AND METHODS: Thirty-two non-small cell lung cancer patients with N3 disease undergoing proton radiation therapy were included. Sinoatrial and AV nodes, along with standard OARs, were delineated. Dosimetric analysis and optimization were performed using intensity-modulated proton therapy. RESULTS: Patients surpassing a predefined SA node dose threshold underwent dose optimization. Proton radiation therapy with pencil beam scanning demonstrated a significant reduction in SA and AV node doses without compromising target volume coverage or significant shift in the dose to other monitored OARs. CONCLUSION: Dose reduction to the SA and AV nodes for pencil beam scanning is a relatively simple task, and the reduction can be very substantial. Larger cohort studies and diverse radiotherapeutic modalities are needed for further validation and refinement of dose constraints.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25002044
- 003
- CZ-PrNML
- 005
- 20250123102029.0
- 007
- ta
- 008
- 250117e20240926xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpt.2024.100631 $2 doi
- 035 __
- $a (PubMed)39399817
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Domanský, Martin $u Proton Therapy Center Czech, Prague, Czech Republic $u Department of Oncology, 2nd Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague, Czech Republic
- 245 10
- $a Cardiac Conduction System as an OAR in Radiation Therapy: Doses to SA/AV Nodes and Their Reduction / $c M. Domanský, M. Andrlík, S. Kurucz, J. Vilimovský, SA. Salih, D. Šimánková, J. Kubeš
- 520 9_
- $a PURPOSE: Despite advancements in radiation techniques, concerns persist regarding the adverse effects of radiation therapy, particularly cardiotoxicity or radiation-induced heart disease. Recently, arrhythmogenic toxicity has come to the forefront-the impact of radiation therapy on the cardiac conduction system. Our objective was to conduct a dosimetric study and subsequently investigate the feasibility of optimizing the sinoatrial (SA) and atrioventricular (AV) nodes as organs at risk (OARs) in proton radiation therapy for non-small cell lung cancer with N3 disease. PATIENTS AND METHODS: Thirty-two non-small cell lung cancer patients with N3 disease undergoing proton radiation therapy were included. Sinoatrial and AV nodes, along with standard OARs, were delineated. Dosimetric analysis and optimization were performed using intensity-modulated proton therapy. RESULTS: Patients surpassing a predefined SA node dose threshold underwent dose optimization. Proton radiation therapy with pencil beam scanning demonstrated a significant reduction in SA and AV node doses without compromising target volume coverage or significant shift in the dose to other monitored OARs. CONCLUSION: Dose reduction to the SA and AV nodes for pencil beam scanning is a relatively simple task, and the reduction can be very substantial. Larger cohort studies and diverse radiotherapeutic modalities are needed for further validation and refinement of dose constraints.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Andrlík, Michal $u Proton Therapy Center Czech, Prague, Czech Republic
- 700 1_
- $a Kurucz, Samuel $u Proton Therapy Center Czech, Prague, Czech Republic
- 700 1_
- $a Vilimovský, Jan $u Proton Therapy Center Czech, Prague, Czech Republic
- 700 1_
- $a Salih, Sarah Al-Hamami $u Proton Therapy Center Czech, Prague, Czech Republic
- 700 1_
- $a Šimánková, Daniela $u Institute of Nuclear Medicine, First Medical Faculty Charles University, General University Hospital Prague, Prague, Czech Republic
- 700 1_
- $a Kubeš, Jiří $u Proton Therapy Center Czech, Prague, Czech Republic
- 773 0_
- $w MED00215028 $t International journal of particle therapy $x 2331-5180 $g Roč. 14 (20240926), s. 100631
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39399817 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250117 $b ABA008
- 991 __
- $a 20250123102023 $b ABA008
- 999 __
- $a ok $b bmc $g 2254459 $s 1238047
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 14 $c - $d 100631 $e 20240926 $i 2331-5180 $m International journal of particle therapy $n Int J Part Ther $x MED00215028
- LZP __
- $a Pubmed-20250117